IP Library Granted Patent US 10,383,952
Granted Patent B2
US 10,383,952 · App. 15/387,067 · Granted Aug 20, 2019

Ionizable cationic lipid for RNA delivery

Inventors: Joseph E. Payne (San Diego, CA); Padmanabh Chivukula (San Diego, CA); Priya Karmali (San Diego, CA); Steven P. Tanis (Carlsbad, CA)
Assignee: Arcturus Therapeutics, Inc.
A61K48/0025A61K9/5123A61K47/20C07C333/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,383,952
App. No.
15/387,067
Granted
Aug 20, 2019
Kind
B2
Abstract

What is described is a compound of formula I consisting of a compound in which R 1 is a branched chain alkyl consisting of 10 to 31 carbons; R 2 is a linear alkyl, alkenyl, or alkynyl consisting of 2 to 20 carbons; L 1 and L 2 are the same or different, each a linear alkylene of 1 to 20 carbons or a linear alkenylene of 2 to 20 carbons; X 1 is S or O; R 3 is a linear or branched alkylene consisting of 1 to 6 carbons; and R 4 and R 5 are the same or different, each a hydrogen or a linear or branched alkyl consisting of 1 to 6 carbons; or a pharmaceutically acceptable salt thereof.

Claims (26)

1. A compound of formula I

wherein

R 1 is CH((CH 2 ) n CH 3 ) 2 or CH((CH 2 ) n CH 3 )((CH 2 ) n-1 CH 3 ) wherein n is 4, 5, 6, 7, or 8,

R 2 is a linear alkyl, alkenyl or alkynyl consisting of 2 to 20 carbons,

R 3 is a linear or branched alkylene consisting of 1 to 6 carbons,

R 4 and R 5 are the same or different, each a hydrogen or a linear or branched alkyl consisting of 1 to 6 carbons;

L 1 is a linear alkylene of 1 to 3 carbons,

L 2 is a linear alkylene of 1 to 5 carbons, and

X 1 is S;

or a salt or solvate thereof.

2. The compound of claim 1 , wherein R 3 consists of ethylene or propylene.

3. The compound of claim 1 , wherein R 4 and R 5 separately are methyl or ethyl.

4. The compound of claim 1 , wherein L 2 is an alkylene consisting of 1, 2, or 3 carbons.

5. The compound of claim 1 , wherein R 2 is an alkenyl.

6. The compound of claim 5 wherein R 2 is an alkenyl consisting of 9 carbons.

7. The compound of claim 1 , wherein n is 5 and L 1 is an alkylene consisting of 1 or 3 carbons.

8. The compound of claim 1 , wherein n is 6 and L 1 is an alkylene consisting of 3 carbons.

9. The compound of claim 1 , wherein n is 7.

10. The compound of claim 1 , wherein n is 8 and L 1 is an alkylene consisting of 1 or 3 carbons.

11. The compound of claim 5 , wherein R 1 consists of —CH((CH 2 ) n CH 3 )((CH 2 ) n-1 CH 3 ), wherein n is 7 or 8.

12. A compound selected from the group consisting of compounds of formulas ATX-43, ATX-57, ATX-58, ATX-61, ATX-63, ATX-64, ATX-81, ATX-82, ATX-83, ATX-86, ATX-87, and ATX-88

or a salt or solvate thereof.

13. The compound of claim 12 of formula ATX-57

14. The compound of claim 12 of formula ATX-58

15. The compound of claim 12 of formula ATX-81

16. The compound of claim 12 of formula ATX-88

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2017
From: PAYNE, JOSEPH E.; CHIVUKULA, PADMANABH; KARMALI, PRIYA; TANIS, STEVEN P.
To: ARCTURUS THERAPEUTICS, INC.
Reel/Frame 041051/0670 →
Continuity (1)
Related Publication 20180169268A1 · Jun 21, 2018
Cited By (7)
US 50,681 US 12,311,033 US 12,460,231 US 12,527,881 US 12,545,912 US 12,703,858 US 12,723,023